Literature DB >> 21161237

[Successful treatment of orbital capillary hemangioma with propranolol].

C Mai1, A Vega-Pérez, M Koch, E Bertelmann.   

Abstract

We describe the case of a 3-month-old infant suffering from rapidly progressive orbital capillary hemangioma which we treated with systemic propranolol over a period of 3.5 months. A few weeks after the onset of treatment, the exophthalmus had regressed and after 3 months of treatment the tumor completely vanished. This result is consistent with recent publications and supports the role of propranolol in the treatment of problematic hemangioma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21161237     DOI: 10.1007/s00347-010-2281-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  9 in total

1.  Beta blockade induces apoptosis in cultured capillary endothelial cells.

Authors:  Sally K Sommers Smith; Dennis M Smith
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

Review 2.  Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.

Authors:  C H Storch; P H Hoeger
Journal:  Br J Dermatol       Date:  2010-05-08       Impact factor: 9.302

3.  [Infantile hemangioma. Successful treatment with propranolol].

Authors:  J Baetz; S Eigelshoven; J Marquard; D Bruch-Gerharz; B Homey; T Meissner
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

4.  Hemangiomas in infancy and childhood. S 2k Guideline of the German Society of Dermatology with the working group Pediatric Dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine.

Authors:  Rainer Grantzow; Peter Schmittenbecher; Hansjörg Cremer; Peter Höger; Jochen Rössler; Henning Hamm; Ulrich Hohenleutner
Journal:  J Dtsch Dermatol Ges       Date:  2008-02-25       Impact factor: 5.584

5.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 6.  Propranolol therapy for infantile haemangiomas: review of the literature.

Authors:  A P Zimmermann; S Wiegand; J A Werner; B Eivazi
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-02-01       Impact factor: 1.675

7.  Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

Authors:  Lisa M Buckmiller; Patrick D Munson; Umesh Dyamenahalli; Yuemeng Dai; Gresham T Richter
Journal:  Laryngoscope       Date:  2010-04       Impact factor: 3.325

8.  [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].

Authors:  H Löffler; C Kosel; H Cremer; W Kachel
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

9.  Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.

Authors:  Beth A Drolet; Elizabeth A Swanson; Ilona J Frieden
Journal:  J Pediatr       Date:  2008-11       Impact factor: 4.406

  9 in total
  1 in total

1.  Oral propranolol for treatment of pediatric capillary hemangiomas.

Authors:  Maryam Aletaha; Hossein Salour; Abbas Bagheri; Nasrin Raffati; Nassim Amouhashemi
Journal:  J Ophthalmic Vis Res       Date:  2012-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.